Krensavage Asset Management Lowers stake in Orthofix International NV (OFIX)

Orthofix International NV (OFIX) : Krensavage Asset Management reduced its stake in Orthofix International NV by 1.02% during the most recent quarter end. The investment management company now holds a total of 639,851 shares of Orthofix International NV which is valued at $23,802,457 after selling 6,595 shares in Orthofix International NV , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Orthofix International NV makes up approximately 8.63% of Krensavage Asset Management’s portfolio.

Other Hedge Funds, Including , Schwab Charles Investment Management Inc boosted its stake in OFIX in the latest quarter, The investment management firm added 49,569 additional shares and now holds a total of 117,378 shares of Orthofix International NV which is valued at $4,366,462. Orthofix International NV makes up approx 0.01% of Schwab Charles Investment Management Inc’s portfolio. Quadrature Capital Ltd sold out all of its stake in OFIX during the most recent quarter. The investment firm sold 5,537 shares of OFIX which is valued $204,260.Blackrock Institutional Trust Company N.a. reduced its stake in OFIX by selling 35,234 shares or 5.87% in the most recent quarter. The Hedge Fund company now holds 565,063 shares of OFIX which is valued at $20,856,475.Acadian Asset Management boosted its stake in OFIX in the latest quarter, The investment management firm added 11,334 additional shares and now holds a total of 671,530 shares of Orthofix International NV which is valued at $26,773,901. Orthofix International NV makes up approx 0.13% of Acadian Asset Management’s portfolio.

Orthofix International NV opened for trading at $37.95 and hit $38.67 on the upside on Monday, eventually ending the session at $38.37, with a gain of 0.92% or 0.35 points. The heightened volatility saw the trading volume jump to 1,22,653 shares. Company has a market cap of $684 M.

On the company’s financial health, Orthofix International NV reported $0.36 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Oct 31, 2016. Analyst had a consensus of $0.31. The company had revenue of $98.50 million for the quarter, compared to analysts expectations of $103.40 million. The company’s revenue was down -2.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.30 EPS.

Orthofix International N.V. (Orthofix) is a diversified global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians across the world. The company operates in four segments: BioStim Biologics Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts Trinity ELITE and Trinity Evolution among others. Its Extremity Fixation solutions include Fixator and Galaxy Fixation System among others. Its Spine Fixation solutions products include NewBridge Laminoplasty Fixation System and PILLAR PL & TL PEEK VBR System among others. It uses independent distributors as well as directly distributes its products in the United States Italy the United Kingdom Germany Switzerland Austria France Brazil Australia and Puerto Rico.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Orthofix International NV - Is it time to Sell?

Top Brokerage Firms are advising their investors on Orthofix International NV. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.